To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
Status:
Terminated
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to enable optimal dose selection of LFF269 for potential future
studies by providing additional information about the compounds safety, tolerability,
pharmacokinetic and pharmacodynamic profiles.